Concord Medical Services ... (CCM)
NYSE: CCM
· Real-Time Price · USD
5.49
0.30 (5.78%)
At close: Jun 26, 2025, 3:07 PM
5.15
-6.19%
After-hours: Jun 26, 2025, 05:23 PM EDT
Concord Medical Services Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Equipment Leasing Revenues Revenue | 9.36M | 16.74M | 21.97M |
| Equipment Leasing Revenues Revenue Growth | -44.10% | -23.80% | n/a |
| Medicine income Revenue | 83.02M | 100.46M | 87.09M |
| Medicine income Revenue Growth | -17.36% | +15.36% | n/a |
| Services and other revenues Revenue | 372.06M | 500.07M | 518.5M |
| Services and other revenues Revenue Growth | -25.60% | -3.55% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|
| China Revenue | 472.08M | 485.63M | 149.55M | 302.3M | 443.6M | 597.75M |
| China Revenue Growth | -2.79% | +224.73% | -50.53% | -31.85% | -25.79% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 78.07M | 78.07M | 104.89M | 104.89M | 88.3M | 88.3M | 107.88M | 107.88M | 78.44M | 78.44M | 107.57M | 107.57M | 93.14M | 93.14M | 82.05M | 82.05M | 78.25M | 78.25M | 97.52M | 97.52M | 75.17M | 75.17M | 94.3M | 94.3M | 62.49M | 62.49M | 67.47M | 67.47M | 73.16M | 73.16M | 79.56M | 79.56M | 56.72M | 60.17M | 76.52M | 62.38M | 59.53M | 47.34M |
| Selling, General, and Administrative Revenue Growth | 0.00% | -25.56% | 0.00% | +18.78% | 0.00% | -18.15% | 0.00% | +37.53% | 0.00% | -27.08% | 0.00% | +15.48% | 0.00% | +13.53% | 0.00% | +4.86% | 0.00% | -19.76% | 0.00% | +29.72% | 0.00% | -20.28% | 0.00% | +50.91% | 0.00% | -7.39% | 0.00% | -7.78% | 0.00% | -8.05% | 0.00% | +40.27% | -5.73% | -21.37% | +22.67% | +4.78% | +25.76% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 12.49M | 12.49M | 14.97M | 14.97M | 13.18M | 13.18M | 17.53M | 17.53M | 13.21M | 13.21M | 20M | 20M | 6.83M | 6.83M | 1.83M | 1.83M | 11.05M | 11.05M | 9.71M | 9.71M | 5.41M | 5.41M | 5.55M | 5.55M | 5.31M | 5.31M | 6.55M | 6.55M | 15.26M | 15.26M | 14.34M | 14.34M | 23.01M | 18.4M | 29.24M | 30.84M | 26.83M | 25.91M |
| Sales and Marketing Revenue Growth | 0.00% | -16.57% | 0.00% | +13.56% | 0.00% | -24.82% | 0.00% | +32.73% | 0.00% | -33.98% | 0.00% | +192.79% | 0.00% | +272.75% | 0.00% | -83.41% | 0.00% | +13.81% | 0.00% | +79.31% | 0.00% | -2.43% | 0.00% | +4.48% | 0.00% | -18.89% | 0.00% | -57.08% | 0.00% | +6.39% | 0.00% | -37.68% | +25.07% | -37.07% | -5.19% | +14.93% | +3.56% | n/a |